Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
10/26/1994 | EP0620741A1 Cytotoxic drug therapy |
10/26/1994 | EP0620739A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
10/26/1994 | EP0174366B1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
10/26/1994 | CN1094093A Progenitor B cell stinulating factor |
10/26/1994 | CN1094092A Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
10/26/1994 | CN1094061A Simultaneous determination of HbALc and haemoglobin variants with a glycation analogeous to HbALc |
10/25/1994 | US5359135 Detection in soil, water, air by preferential affinity to monoclonal antibodies |
10/25/1994 | US5359115 Reacting phosphonic monoester with dialkylazodicarboxylate, triphenylphosphine and secondary alcohol to form diester, hydrolyzing selective ester to form monoester, coupling an aminoacid to yield peptidylphosphonate |
10/25/1994 | US5359093 For sensitive immunoassays |
10/25/1994 | US5359047 Nucleic acids encoding DNA structure-specific recognition protein and uses therefor |
10/25/1994 | US5359046 Chimeric chains for receptor-associated signal transduction pathways |
10/25/1994 | US5359045 DNA sequence encoding a polypeptide including nucleic acid encoding amino acids 361-404 and 951-1002 |
10/25/1994 | US5359038 Placing feces in a container with phosphate saline buffer, homogenizing, separating solids, leaving clear solution, precipitation of all material in except immunoglobulins by using protamine, analyzing for antigens and antibodies |
10/25/1994 | US5359037 Antibodies to TNF binding protein I |
10/25/1994 | US5359031 Unique protein marker for bladder cancer |
10/25/1994 | US5358960 Method for inhibiting advanced glycosylation of proteins using aminosubstituted imidazoles |
10/25/1994 | US5358867 DNA cloning and expression of an L7 protein which modulates the 2'-5' oligosynthetase and H2-K*K response to type-I interferon |
10/25/1994 | US5358851 Polyclonal antibody from immunizing an animal with immunogenic carrier protein conjugated to p-tolylacetic acid, then binding product to the aromatic ring of benzene or naphthalene derivatives for detection |
10/25/1994 | US5358849 Hybridomas; culture products; radioisotope labelling; cancer screening |
10/25/1994 | US5358710 Administering an immunosuppressant amount of a tolerogenic conjugate of an antigenic polypeptide covalently bound to a water soluble polymer |
10/25/1994 | US5358649 Diagnosis for porcine malignant hyperthermia |
10/23/1994 | CA2121096A1 Monoclonal antibodies to bovine cytokines |
10/21/1994 | CA2116261A1 Epitopic regions of pneumococcal surface protein a |
10/19/1994 | EP0620276A1 Humanised antibodies |
10/19/1994 | EP0620231A1 Human parvovirus B19 epitope-related peptide |
10/19/1994 | EP0620011A1 Antibody-drug conjugates |
10/19/1994 | EP0619843A1 Icams immunoglobulin constant region soluble fusion proteins |
10/19/1994 | EP0619841A1 T-cadherin adhesion molecule |
10/19/1994 | EP0619839A1 Novel polypeptides for promoting cell attachment |
10/19/1994 | EP0619824A1 Trophoblast interferons and their use |
10/19/1994 | EP0619738A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
10/19/1994 | EP0556271B1 Biological active material covalently immobilized on to azlactone-functional polymeric supports and method for preparing it |
10/19/1994 | EP0515536A4 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules |
10/19/1994 | EP0471701B1 Novel tnf-inhibit proteins and their preparation |
10/19/1994 | CN1093751A Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
10/18/1994 | US5357042 Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity |
10/18/1994 | US5356895 1,4 piperizino inhibitors of non-enzymatic cross-linking of proteins |
10/18/1994 | US5356820 Haptens, tracers, immunogens and antibodies for immunoassays for propoxyphene |
10/18/1994 | US5356622 Homogenizing and sonicating flea midgut, separating and recovering |
10/18/1994 | US5356374 Process for treating blood with polyimide carriers |
10/17/1994 | CA2121302A1 Amphotropic virus receptor |
10/13/1994 | WO1994023302A1 Immunological assay of oxidatively modified human low density lipoproteins in plasma |
10/13/1994 | WO1994023033A1 Human osteoclast-specific and -related genes |
10/13/1994 | WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
10/13/1994 | WO1994023030A2 Methods and materials relating to the functional domains of dna binding proteins |
10/13/1994 | WO1994023018A1 Immunoassay for tetrachloroisophthalonitrile (chlorothalonil®), its derivatives and breakdown products |
10/13/1994 | WO1994023016A1 Cell matrix stimulated cell attachment and hemidesmosome assembly |
10/13/1994 | WO1994023015A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
10/13/1994 | WO1994022918A1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof |
10/13/1994 | WO1994022915A1 Inhibitor of stem cell proliferation and uses thereof |
10/13/1994 | WO1994022912A1 Antigenic polypeptides of t. ovis and vaccines containing such polypeptides |
10/13/1994 | WO1994022902A1 IN VITRO REFOLDING OF RECOMBINANT Fv FRAGMENTS |
10/13/1994 | WO1994022490A1 Conjugates of proteins and bifunctional ligands |
10/13/1994 | WO1994022479A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
10/13/1994 | WO1994022478A1 PREVENTION OF TUMORS WITH MONOCLONAL ANTIBODIES AGAINST $i(NEU) |
10/13/1994 | WO1994022475A1 Cloned leptospira outer membrane protein |
10/13/1994 | WO1994022472A1 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
10/13/1994 | WO1994018332A3 Anthrax toxin fusion proteins and uses thereof |
10/13/1994 | WO1994018227A3 Improved method for the refolding of proteins |
10/13/1994 | WO1994017828A3 Treatment for insulin dependent diabetes |
10/13/1994 | WO1994017189A3 Protein kinases |
10/13/1994 | WO1994012635A3 Novel seven transmembrane receptors |
10/13/1994 | CA2164123A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
10/13/1994 | CA2159506A1 Inhibitor of stem cell proliferation and uses thereof |
10/13/1994 | CA2159471A1 Cell matrix stimulated cell attachment and hemidesmosome assembly |
10/13/1994 | CA2159114A1 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
10/13/1994 | CA2159080A1 Human osteoclast-specific and -related genes |
10/13/1994 | CA2158540A1 Cloned leptospira outer membrane protein |
10/13/1994 | CA2158056A1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof |
10/13/1994 | CA2135912A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
10/12/1994 | EP0619324A1 HUMAN TYPE ANTIBODY REACTIVE WITH GPIIb/IIIa |
10/12/1994 | EP0619323A1 Human monoclonal antibodies and processes and materials for making such antibodies |
10/12/1994 | EP0619321A1 Very large scale immobilized peptide synthesis |
10/12/1994 | EP0618978A1 In vitro antibody production |
10/12/1994 | EP0618977A1 Expression-secretion vectors for the production of biologically active fv fragments |
10/12/1994 | EP0618970A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
10/12/1994 | EP0618969A1 Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
10/12/1994 | EP0618968A1 Tools for the diagnosis and treatment of alzheimer's disease |
10/12/1994 | EP0618967A1 Ifn-gamma antagonist cytokine |
10/12/1994 | EP0618965A1 Method for generating structural and functional diversity in a peptide sequence |
10/12/1994 | EP0618930A1 Monoclonal antibody to hiv-2 and uses thereof |
10/12/1994 | EP0618929A1 Bispecific antibody heterodimers |
10/12/1994 | EP0618928A1 Pharmaceutical composition containing anti-allergenic antibodies, method of purifying said antibodies and antibodies thus obtained |
10/12/1994 | EP0618927A1 Cytokines with an unpaired cysteine residue and conjugates thereof |
10/12/1994 | EP0618914A1 Oxiranyl methyl ethers exhibiting chirality, and their use as dopants in liquid-crystal mixtures |
10/12/1994 | EP0618891A1 Method for making valproic acid derivatives |
10/12/1994 | EP0618816A1 Further improvements relating to the radiolabelling of proteins |
10/12/1994 | EP0618804A1 Peptides corresponding to antigenic determinants of htlv |
10/12/1994 | EP0618803A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
10/12/1994 | EP0618802A1 Synthetic compounds and compositions with enhanced cell binding |
10/12/1994 | EP0494294B1 Bacterial stress proteins |
10/11/1994 | US5354847 Chimeric antibody with specificity to human tumor antigen |
10/11/1994 | US5354765 Synergistic |
10/11/1994 | US5354736 Synthetic compounds and compositions with enhanced cell binding |
10/11/1994 | US5354661 Monoclonal antibody to enterohemorrhagic Escherichia coli 0157:H7 and 026:H11 and method for detection |
10/11/1994 | CA1332367C Method for the reduction of heterogeneity of monoclonal antibodies |
10/06/1994 | DE4310529A1 Monoclonal antibodies C10 and F1, antibody-producing hybridoma cells and use of the antibodies as markers for a resistance gene |
10/05/1994 | EP0618448A1 Method to detect bone and other connective tissue disorders in humans and animals |
10/05/1994 | EP0618293A1 Human contactin, a cell adhesion molecule |
10/05/1994 | EP0618231A1 Immunologically active conjugates and a method for their preparation |